Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock ...Middle East

WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved...

Read More Details
Finally We wish PressBee provided you with enough information of ( Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock )

Also on site :

• Death toll in Iran port explosion mounts to 25
• Mass shooting in Myrtle Beach tourist hotspot leaves 11 injured, suspect killed by police
• What happens after Pope Francis funeral – how the Conclave to select his successor will work